Collaborations play an important role in helping us to bring ferric citrate, brand name Auryxia® in the U.S., to people around the world. Today, this medicine is approved in the U.S., Japan and the European Union. We seek to work with companies that share our commitment to improving the lives of patients with renal disease.

The First and Only Absorbable-Iron-Based Phosphate Binder

global_graph

Learn more at www.auryxia.com